Your browser doesn't support javascript.
loading
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Atsuta, Yoshiko; Baldomero, Helen; Neumann, Daniel; Sureda, Anna; DeVos, Jakob D; Iida, Minako; Karduss, Amado; Purtill, Duncan; Elhaddad, Alaa M; Bazuaye, Nosa G; Bonfim, Carmem; De la Camara, Rafael; Chaudhri, Naeem A; Ciceri, Fabio; Correa, Cinthya; Frutos, Cristobal; Galeano, Sebastian; Garderet, Laurent; Gonzalez-Ramella, Oscar; Greco, Raffaella; Hamad, Nada; Hazenberg, Mette D; Horowitz, Mary M; Kalwak, Krzysztof; Ko, Bor-Sheng; Kodera, Yoshihisa; Koh, Mickey Bc; Liu, Kaiyan; McLornan, Donal P; Moon, Joon Ho; Neven, Benedicte; Okamoto, Shinichiro; Pasquini, Marcelo C; Passweg, Jakob R; Paulson, Kristjan; Rondelli, Damiano; Ruggeri, Annalisa; Seber, Adriana; Snowden, John A; Srivastava, Alok; Szer, Jeff; Weisdorf, Daniel; Worel, Nina; Greinix, Hildegard; Saber, Wael; Aljurf, Mahmoud; Niederwieser, Dietger.
Affiliation
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute. y-atsuta@jdchct.or.jp.
  • Baldomero H; The Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, University Hospital, Basel, CH.
  • Neumann D; Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig.
  • Sureda A; Clinical Hematology Department, Institut Català d'Onvcologia - L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona.
  • DeVos JD; Center for International Blood and Marrow Transplant Resaerch, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Iida M; Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute.
  • Karduss A; Instituto de Cancerología-Clínica Las Américas, Medellín, Colombia.
  • Purtill D; Haematology Department, Fiona Stanley Hospital, Murdoch, Australia.
  • Elhaddad AM; Department of Pediatric Oncology and Stem Cell Transplantation Unit, Cairo University Cairo, Egypt.
  • Bazuaye NG; Department of Hematology and Blood Transfusion, University of Benin Teaching Hospital, Edo State, Nigeria.
  • Bonfim C; Pele Pequeno Principe Research Institute/ Pediatric Blood and Marrow Transplantation Program Hospital Pequeno Principe, Curitiba, Brazil.
  • De la Camara R; Hematology Department, Hospital de la Princesa, Madrid.
  • Chaudhri NA; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Ciceri F; Ospedale San Raffaele s.r.l., Haematology and BMT, Milano.
  • Correa C; Hospital Israelita Albert Eisntein, Sao Paula Brazil.
  • Frutos C; Instituto de Previsión Social, Asunción, Paraguay.
  • Galeano S; Hospital Británico, Montevideo, Uruguay.
  • Garderet L; Sorbonne Université, Service d'Hématologie et thérapie cellulaire, HôpitalPitié Salpêtrière, AP-HP, Paris, France .
  • Gonzalez-Ramella O; Hospital Civil de Guadalajara, Dr Juan I Menchaca, Guadalajara, Mexico.
  • Greco R; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Milan.
  • Hamad N; Haematology Clinical Research Unit, St. Vincent's Health Network, Kinghorn Cancer Centre, Sydney, Australia.
  • Hazenberg MD; Department of Hematology, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam.
  • Horowitz MM; Center for International Blood and Marrow Transplant Resaerch, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Kalwak K; Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wroclaw.
  • Ko BS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Kodera Y; Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute.
  • Koh MB; Institute for Infection and Immunity St. George's Hospital and Medical School, University of London, London.
  • Liu K; Department of Hematology, Peking University Institute of Hematology, Beijing.
  • McLornan DP; Department of Haematology, University College Hospital, London.
  • Moon JH; Division of Hematology-Oncology, Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea.
  • Neven B; Service d'immunologie-Hématologie Et Rhumatologie Pédiatrique, Hôpital Necker-Enfants Malades, Assistance Publique des Hôpitaux de Paris, INSERM, Paris.
  • Okamoto S; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo.
  • Pasquini MC; Center for International Blood and Marrow Transplant Resaerch, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Passweg JR; The Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, University Hospital, Basel, CH.
  • Paulson K; Section of Haematology/Oncology, Department of Internal Medicine, Max Rady College of Medicine, the University of Manitoba, Winnipeg, Manitoba, Canada.
  • Rondelli D; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL.
  • Ruggeri A; Hematology and BMT Unit, San Raffaele Scientific Institute, Milano.
  • Seber A; Department of Medicine, Universidade Federal de Sao Paulo Escola Paulista de Medicina: Sao Paulo, Brazil.
  • Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Srivastava A; Department of Hematology, Christian Medical College Hospital, Vellore.
  • Szer J; Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Worel N; Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna.
  • Greinix H; Division of Hematology, Medical University of Graz, Graz.
  • Saber W; Center for International Blood and Marrow Transplant Resaerch, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Aljurf M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Niederwieser D; Division of Hematology and Medical Oncology, University of Leipzig, Leipzig.
Haematologica ; 109(10): 3282-3294, 2024 Oct 01.
Article in En | MEDLINE | ID: mdl-38721749
ABSTRACT
Promoting access to and excellence in hematopoietic cell transplantation (HCT) by collecting and disseminating data on global HCT activities is one of the principal activities of the Worldwide Network for Blood and Marrow Transplantation, a non-governmental organization in working relations with the World Health Organization. HCT activities are recorded annually by member societies, national registries and individual centers including indication, donor type (allogeneic/autologous), donor match and stem cell source (bone marrow/peripheral blood stem cells/cord blood). In 2018, 1,768 HCT teams in 89 countries (6 World Health Organization regions) reported 93,105 (48,680 autologous and 44,425 allogeneic) HCT. Major indications were plasma cell disorders and lymphoma for autologous, and acute leukemias and MDS/MPN for allogeneic HCT. HCT numbers increased from 48,709 in 2007. Notable increases were seen for autoimmune diseases in autologous and hemoglobinopathies in allogeneic HCT. The number of allogeneic HCT more than doubled with significant changes in donor match. While HCT from HLA-identical siblings has seen only limited growth, HCT from non-identical related donors showed significant increase worldwide. Strongest correlation between economic growth indicator of gross national income/capita and HCT activity/10 million population was observed for autologous HCT (correlation coefficient [r]=0.79). HCT from unrelated donors showed strong correlation (r=0.68), but only moderate correlation was detected from related donors (r=0.48 for HLA-identical sibling; r=0.45 for other). The use of HCT doubled in about a decade worldwide at different speed and with significant changes regarding donor match as a sign of improved access to HCT worldwide. Although narrowing, significant gaps remain between developing and non-developing countries.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Unrelated Donors Limits: Humans Language: En Journal: Haematologica Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Unrelated Donors Limits: Humans Language: En Journal: Haematologica Year: 2024 Document type: Article Country of publication: